Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers

2017 ◽  
Vol 209 (6) ◽  
pp. W365-W373 ◽  
Author(s):  
Satheesh Krishna ◽  
Matthew McInnes ◽  
Christopher Lim ◽  
Robert Lim ◽  
Shaheed W. Hakim ◽  
...  
Keyword(s):  
Gleason Score ◽  
Peripheral Zone ◽  
Data System ◽  
Prostate Imaging

scholarly journals Interobserver agreement of Prostate Imaging–Reporting and Data System (PI-RADS–v2)

2021 ◽  
Vol 52 (1) ◽  
Author(s):  
Hala Maher Ahmed ◽  
Ahmed Ebrahim Ebeed ◽  
Ahmed Hamdy ◽  
Mohamed Abou El-Ghar ◽  
Ahmed Abdel Khalek Abdel Razek
Keyword(s):  
Interobserver Agreement ◽  
Imaging Modality ◽  
Peripheral Zone ◽  
Transitional Zone ◽  
Data System ◽  
3 Tesla ◽  
Prostate Imaging ◽  
Percent Agreement ◽  
3 Tesla Mri

Abstract Background A retrospective study was conducted on 71 consecutive patients with suspected prostate cancer (PCa) with a mean age of 56 years and underwent mp-MRI of the prostate at 3 Tesla MRI. Two readers recognized all prostatic lesions, and each lesion had a score according to Prostate Imaging–Reporting and Data System version 2 (PI-RADS-v2). Purpose of the study To evaluate the interobserver agreement of PI-RADS-v2 in characterization of prostatic lesions using multiparametric MRI (mp-MRI) at 3 Tesla MRI. Results The overall interobserver agreement of PI-RADS-v2 for both zones was excellent (k = 0.81, percent agreement = 94.9%). In the peripheral zone (PZ) lesions are the interobserver agreement for PI-RADS II (k = 0.78, percent agreement = 83.9%), PI-RADS III (k = 0.66, percent agreement = 91.3 %), PI-RADS IV (k = 0.69, percent agreement = 93.5%), and PI-RADS V (k = 0.91, percent agreement = 95.7 %). In the transitional zone (TZ) lesions are the interobserver agreement for PI-RADS I (k = 0.98, percent of agreement = 96%), PI-RADS II (k = 0.65, percent agreement = 96%), PI-RADS III (k = 0.65, percent agreement = 88%), PI-RADS IV (k = 0.83, percent agreement = 96%), and PI-RADS V (k = 0.82, percent agreement = 92%). Conclusion We concluded that PI-RADS-v2 is a reliable and a reproducible imaging modality for the characterization of prostatic lesions and detection of PCa.

scholarly journals Comparing Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) Category 1 and 2 Groups: Clinical Implication of Negative Multiparametric Magnetic Resonance Imaging

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Jung Kwon Kim ◽  
Hak Jong Lee ◽  
Sung Il Hwang ◽  
Gheeyoung Choe ◽  
Sung Kyu Hong
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Gleason Score ◽  
Univariate Analysis ◽  
Data System ◽  
Resonance Imaging ◽  
Fusion Biopsy ◽  
Prostate Imaging ◽  
Gleason Pattern ◽  
Clinical Databases

Objectives. To evaluate the clinicopathological differences between Prostate Imaging-Reporting and Data System (PI-RADS) version 2 (v2) category 1 and 2 groups. Materials and Methods. We retrospectively reviewed our two institutional clinical databases: (1) transrectal ultrasound (TRUS)/magnetic resonance imaging (MRI) fusion biopsy cohort (n=706) and (2) radical prostatectomy (RP) cohort (n=1403). Subsequently, we performed comparative analyses between PI-RADSv2 category 1 and 2 groups. Clinically significant prostate cancer (csPCa) was defined as the presence of Gleason score GS≥3+4 in a single biopsy core, and adverse pathology (AP) was defined as high-grade (primary Gleason pattern 4 or any pattern 5) and/or non-organ-confined disease (pT3/N1). We also performed multivariate logistic regression analyses for AP. Results. In the TRUS/MRI fusion biopsy cohort, no significant differences in detection rates of all cancer (18.2% vs. 29.0%, respectively, P=0.730) or csPCa (9.1% vs. 9.9%, respectively, P=0.692) were observed between PI-RADSv2 category 1 and 2 groups. There were no significant differences in pathologic outcomes including Gleason score (≥4+3, 21.2% vs. 29.9%, respectively, P=0.420) or detection rate of AP (27.3% vs. 33.8%, respectively, P=0.561) between the two groups in the RP cohort either. PI-RADSv2 category 1 or 2 had no significant association with AP, even in univariate analysis (P=0.299). Conclusions. PI-RADSv2 categories 1 and 2 had similar performance to predict clinicopathological outcomes. Consequently, these two categories may be unified into a single category. Negative mpMRI does not guarantee the absence of AP, as with csPCa.

Prostate Imaging Reporting and Data System, Version 2, Assessment Categories and Pathologic Outcomes in Patients With Gleason Score 3 + 4 = 7 Prostate Cancer Diagnosed at Biopsy

2017 ◽  
Vol 208 (5) ◽  
pp. 1037-1044 ◽  
Author(s):  
Christopher S. Lim ◽  
Matthew D. F. McInnes ◽  
Trevor A. Flood ◽  
Rodney H. Breau ◽  
Christopher Morash ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Gleason Score ◽  
Data System ◽  
Prostate Imaging

scholarly journals The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment

2017 ◽  
Vol 24 (1) ◽  
pp. 44-50
Author(s):  
Paulius Aliukonis ◽  
Tadas Letauta ◽  
Rūta Briedienė ◽  
Ieva Naruševičiūtė ◽  
Simona Letautienė
Keyword(s):  
Gleason Score ◽  
Specific Antigen ◽  
Magnetic Resonance Tomography ◽  
Peripheral Zone ◽  
Focal Lesion ◽  
Predictive Values ◽  
Prostate Imaging ◽  
Subsequent Calculation ◽  
Mri Sequences

Background. Standardised Prostate Imaging Reporting and Data System (PI-RADS) guidelines for the assessment of prostate alterations were designed for the assessment of prostate pathology. Published by the ESUR in 2012, PI-RADS v1 was based on the total score of different MRI sequences with subsequent calculation. PI-RADS v2 was published by the American College of Radiology in 2015 and featured different assessment criteria for prostate peripheral and transitory zones. Aim. To assess the correlations of PI-RADS v1 and PI-RADS v2 with Gleason score values and to define their predictive values of the diagnosis of prostate cancer. Materials and methods. A  retrospective analysis of 66 patients. Prostate specific antigen (PSA) value and the  Gleason score (GS) were assessed. One the most malignant focal lesion was selected in the peripheral zone of each lobe of the prostate (91 in total). Statistical analysis was carried out applying SPSS software, v.23, p 

Sign in / Sign up

Export Citation Format

Share Document